Actively Recruiting
ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies
Led by Fudan University · Updated on 2023-05-31
5000
Participants Needed
1
Research Sites
365 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a community-based prospective study and the research object is breast cancer patients. It is planned to take the community as the unit to inform and collect the breast cancer patients who voluntarily participate to carry out the detection of BRCA1, BRCA2, PTEN, CHEK2 and PALB2 genes through the community health service center.
CONDITIONS
Official Title
ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Breast cancer patients of any age
- Both male and female patients
- Signed informed consent to participate and agree to follow study procedures
You will not qualify if you...
- Healthy individuals or patients with other malignancies without breast cancer
- Unable to communicate with the investigator or sign informed consent
- Unable to provide peripheral blood or oral mucosa samples for any reason
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhen Hu
Shanghai, Shanghai Municipality, China, 200032
Actively Recruiting
Research Team
Z
Zhen Hu, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here